Sleep is a whole-organism phenomenon accompanied by global changes in neural activity. We previously identified SLEEPLESS (SSS) as a glycosylphosphatidyl inositol-anchored protein required for sleep in Drosophila. Here we found that SSS is critical for regulating the sleep-modulating potassium channel Shaker. SSS and Shaker shared similar expression patterns in the brain and specifically affected each other's expression levels. sleepless (sss) loss-of-function mutants exhibited altered Shaker localization, reduced Shaker current density and slower Shaker current kinetics. Transgenic expression of sss in sss mutants rescued defects in Shaker expression and activity cell-autonomously and suggested that SSS functions in wake-promoting, cholinergic neurons. In heterologous cells, SSS accelerated the kinetics of Shaker currents and was co-immunoprecipitated with Shaker, suggesting that SSS modulates Shaker activity via a direct interaction. SSS is predicted to belong to the Ly-6/neurotoxin superfamily, suggesting a mechanism for regulation of neuronal excitability by endogenous toxin-like molecules.
a r t I C l e S In mammals, sleep is associated with broad changes in patterns of neuronal activity in the brain. Sleep in fruit flies shares several features of mammalian sleep, such as circadian and homeostatic regulation and increased arousal threshold 1, 2 , and is similarly accompanied by broad changes in brain activity 3 . Modulation of neuronal excitability may be an essential component of sleep regulation. This view is supported by several studies that found that mice and flies bearing mutations in genes encoding ion channels and their associated proteins have altered sleep [4] [5] [6] [7] [8] . For example, a forward genetic screen led to the identification of a mutation in Shaker, the gene encoding a canonical voltage-gated potassium channel, as the defect underlying a short-sleeping phenotype in Drosophila, and targeted disruption of the mammalian Shaker ortholog, Kv1.2, also leads to reduced sleep in mice 9, 10 .
We recently identified sleepless as a gene required for sleep in Drosophila. sss mutants have a severe reduction in sleep and decreased Shaker expression, providing an additional link between sleep and neuronal excitability 11 . However, the mechanism by which SSS regulates Shaker, and thereby neuronal excitability, is not known. The mature SSS protein, ~15 kDa in size, is cysteine rich and covalently linked to the plasma membrane by a glycosylphosphatidyl-inositol (GPI) anchor 11 . SSS is predicted to belong to the Ly-6/neurotoxin superfamily of proteins 12 . This superfamily includes diverse proteins such as secreted signaling molecules and receptors [13] [14] [15] , as well as snake neurotoxins, which bind to and modulate the activity of various ion channels 12, 16 .
The predicted Ly-6/neurotoxin domain in SSS suggests at least two distinct potential molecular mechanisms of action. One possibility is that SSS acts as a proto-toxin, forming a complex with Shaker to control its expression and activity in the same cell. An endogenous toxin-like molecule that regulates Shaker-type channels has been postulated on the basis of the finding that expression of a Shakerspecific neurotoxin in the endoplasmic reticulum of mammalian cells increases the surface localization of these channels 17 . Alternatively, as SSS is tethered to the cell surface by a GPI anchor and cleavage of the anchor by phospholipase C results in release of SSS into the media in cultured cells 11 , SSS may be a secreted molecule that acts on Shaker indirectly through a receptor-mediated signaling pathway.
In this study, we found that SSS acts as an endogenous toxin-like regulator of Shaker expression, localization and activity. SSS and Shaker shared a similar expression pattern in the Drosophila brain and loss of either SSS or Shaker resulted in a reduction of the other protein, suggesting that these proteins are required for each other's stability. We found that the ability of SSS to promote sleep localized to wake-promoting, cholinergic neurons that were distinct from circuitry involved in sss-dependent, ether-induced leg shaking. In sss mutants, Shaker appeared to be mislocalized and Shaker currents were smaller and slower. Shaker protein levels, current amplitude and kinetics were all rescued in sss mutants in a cell-autonomous manner by targeted expression of a sss transgene. Finally, in heterologous systems, SSS accelerated kinetics of Shaker currents and could be co-immunoprecipitated with Shaker, suggesting that SSS forms a complex with Shaker and regulates its activity. Together, these results establish SSS as a critical regulator of Shaker channels, defining a molecular mechanism for the modulation of neuronal excitability.
RESULTS

Differential rescue of sss mutant phenotypes
We previously found that SSS is markedly enriched in adult brains and that the sss mutant sleep phenotype can be rescued using a 7 0 VOLUME 13 | NUMBER 1 | jaNUaRy 2010 nature neurOSCIenCe a r t I C l e S transgene containing the sss genomic region 11 . To examine the neuronal circuitry required for the sleep phenotype observed in sss mutants, we used the Gal4-UAS system to perform targeted rescue of the sss P1 mutation 18 . We generated transgenic flies bearing Gal4 under the control of the sss promoter (sss-Gal4, see Online Methods) and found that the amount of daily sleep returned to wild-type levels in sss P1 mutant flies carrying both the sss-Gal4 driver and the UAS-sss transgene ( Fig. 1) . By crossing flies bearing the sss-Gal4 driver to those carrying a UAS-GFP transgene, we found that the sss-Gal4 driver was broadly expressed, with prominent enrichment in areas such as the mushroom bodies, a region previously shown to be important for sleep regulation 19, 20 , and antennal nerves, in a pattern that overlaps substantially with the SSS immunostaining pattern ( Fig. 2 and Supplementary Fig. 1 ). Pan-neuronal expression of UAS-sss under the control of the elav-Gal4 driver also fully rescued the sss P1 mutant sleep phenotype ( Fig. 1a) .
Because both sss-Gal4 and elav-Gal4 drivers exhibited broad expression patterns, we also examined whether more restricted sss expression could rescue the mutant sleep phenotype. We screened a number of Gal4 driver lines with varying expression patterns for their ability to rescue reduced sleep in sss mutants. Although several drivers promoted strong rescue, they all had broad expression patterns ( Supplementary Figs. 2 and 3) , making it difficult to pinpoint a specific region in which SSS function is required. Drivers that promoted more restricted expression patterns were associated with little or no rescue; these included drivers that direct expression in the mushroom bodies, clock cells and the pars intercerebralis neurons, areas that have been implicated in sleep regulation [19] [20] [21] [22] [23] [24] [25] . We also examined the effects on sleep of overexpressing SSS in wild-type animals. SSS overexpression using a variety of Gal4 drivers had no substantial effect on the amount of daily sleep (Supplementary Fig. 4) .
To examine whether a specific neurotransmitter system underlies the short-sleeping phenotype of sss mutants, we employed Gal4 drivers that induce expression in different neurotransmitter systems ( Fig. 1b) . Preferentially expressing sss in cholinergic neurons using Cha-Gal4 resulted in strong rescue of the short-sleeping phenotype of sss P1 mutants. In contrast, preferential expression of sss in glutamatergic or dopaminergic neurons, driven by vGlut-or TH-Gal4, respectively, resulted in weak or no rescue of the mutant sleep phenotype. Together, these data suggest that SSS expression in cholinergic, but not glutamatergic or dopaminergic, neurons is important for sleep regulation. However, we cannot exclude the possibility that some noncholinergic neurons also contribute to the strong rescue by Cha-Gal4. As with other drivers that rescue well, the Cha-Gal4 expression pattern is anatomically broad and the regulation of sleep by SSS may therefore involve widely distributed neurons of the Drosophila brain.
Like Shaker mutants, sss mutants display rhythmic leg shaking under ether anesthesia 11, 26 . This leg-shaking phenotype was rescued by SSS expression using the elav-Gal4 and sss-Gal4 drivers (Fig. 1a) . Notably, although the cholinergic driver Cha-Gal4 efficiently rescued the sleep phenotype of sss mutants, it had little effect on leg shaking. In contrast, expression of SSS in glutamatergic neurons with vGlut-Gal4 rescued the leg-shaking phenotype of sss mutants but only weakly rescued the sleep phenotype (Fig. 1b) . These data indicate that the circuits mediating ether-induced leg shaking and sleep regulation are distinct, suggesting that the sleep dysfunction in sss mutants is not caused by a defect in motor neurons.
SSS and Shaker are enriched in the same brain regions
To investigate a possible cell-autonomous role for SSS in regulating Shaker, we sought to determine whether the two proteins shared similar expression patterns in the adult Drosophila brain. To visualize SSS-expressing cells, we generated a new antibody to SSS and performed whole-mount immunostaining of adult brains. SSS immunostaining overlapped appreciably with sss-Gal4-driven GFP expression (compare Fig. 2 and Supplementary Fig. 1 ). SSS-specific immunoreactivity was observed in the mushroom bodies and other structures such as the antennal nerves, superior protocerebrum and the lobula plate of the optic lobes ( Fig. 2a,c) . Loss of SSS immunoreactivity in sss null mutants confirmed the specificity of our antibody ( Fig. 2e) .
To examine the Shaker expression pattern, we also raised a new antibody to Shaker. We found that Shaker and SSS had similar expression patterns, with broad expression throughout the brain, but with clear enrichment in specific structures, including the mushroom bodies, the superior protocerebrum, antennal nerves and neuronal processes in the lobula plate ( Fig. 2b,d ). This staining pattern was specific, as it was absent in Shaker-null (Shaker Df ; B55/W32) 27 brains ( Fig. 2f) , and was similar to that found in a previous Shaker immunohistochemical study 28 . The requirement of different fixatives for the antibodies to SSS and Shaker prevented a direct assessment of colocalization. However, the finding that SSS and Shaker were enriched in similar regions of the brain suggests that SSS regulates Shaker in a cell-autonomous manner.
Shaker and SSS specifically affect each other's expression
We next used our antibody to Shaker to examine the relationship between Shaker and SSS in greater detail. The antibody recognized two bands of apparent molecular weight of ~65-75 kDa on western blots of wild-type fly head extracts, but not in Shaker Df extracts, indicating that the antibody selectively reacts with Shaker protein (Fig. 3a) . Because alternative splicing produces multiple isoforms of Shaker, the two bands may represent different isoforms. Both Shaker bands were reduced in sss P1 mutants, confirming our previous finding that sss promotes Shaker protein expression 11 . In contrast, Shaker mRNA levels were not reduced in sss P1 mutants ( Supplementary Fig. 5 ), indicating that the reduction of Shaker protein in sss mutants is caused by post-transcriptional regulation of Shaker. a r t I C l e S Other short-sleeping mutants, such as DAT fumin and Clk jrk (refs. 29-31), did not have noticeable reductions in Shaker protein ( Fig. 3a) , indicating that decreased sleep is not necessarily linked to a reduction in Shaker expression. In addition, sss did not affect expression of all potassium channels, as levels of Eag protein were comparable in sss mutants and wild-type flies (Fig. 3b) .
To determine whether there is a reciprocal effect of Shaker on SSS expression, we examined SSS levels in Shaker Df mutants and found that SSS expression was reduced compared with controls. SSS levels were not reduced in DAT fumin and Clk jrk mutants ( Fig. 3a and Supplementary Fig. 6 ), providing further evidence for a specific interaction between SSS and Shaker. The mutual effects of SSS and Shaker on each other's expression are consistent with the hypothesis that SSS and Shaker exist in a complex.
Shaker localization is altered in sss mutants
Because neuronal output can be regulated not only by the number of ion channels, but also by their regional and subcellular localization, we examined Shaker staining in whole-mount brains. Consistent with our western blot results ( Fig. 3) , we found that overall Shaker expression was lower in sss mutants than in control flies ( Fig. 4) . However, the degree to which Shaker was reduced in sss mutants was not uniform across brain regions. For instance, Shaker immunoreactivity in sss mutants was greatly reduced in antennal nerves, lobula plate and certain subregions (for example, α and α′ lobes) of the mushroom bodies, but it was not as severely affected in other subregions (for example, γ lobes) of the mushroom bodies ( Fig. 4a,b) .
Furthermore, the subcellular localization of Shaker appeared to be altered in sss mutants. In wild-type animals, Shaker was widely expressed in neuronal fiber tracts. For example, we observed strong Shaker expression in the antennal nerves ( Fig. 4a) , processes originating from visual projection neurons ( Fig. 4c ) and the cervical connective ( Fig. 4e,g) . In contrast, in sss mutants, we found Shaker predominantly in cell bodies of brains ( Fig. 4d ) and thoracic ganglia ( Fig. 4f,h) . We cannot rule out the possibility that SSS is more important for Shaker expression in cells in which Shaker is predominantly expressed in neuronal processes than in cells in which the channel is enriched in cell bodies. However, our data suggest that SSS is required for proper subcellular localization of Shaker, that is, targeting to or retention at neuronal processes.
Targeted expression of sss restores Shaker expression
To address whether SSS regulates Shaker in a cell-autonomous manner, we first examined whether restoration of SSS in specific brain regions of sss mutants selectively rescues Shaker expression in the same regions ( Fig. 5) . We coupled the expression of a sss transgene to the OK107-and vGlut-Gal4 drivers, which have complementary expression patterns in two brain regions in which Shaker is normally enriched. OK107-Gal4 directed GFP expression to the mushroom bodies, but not to a group of visual projection neurons sending processes to the optic lobe, and the opposite was true for the vGlut-Gal4 driver ( Fig. 5a,c, 
e,g).
Using these drivers to express UAS-sss, we found that Shaker expression in sss mutants was restored in the regions in which GFP, and presumably transgenic SSS, was expressed. Thus, restoration of SSS in sss mutants by OK107-Gal4 increased Shaker expression in the mushroom bodies, especially the α and α′ lobes ( Fig. 5b) , but not in the visual projection neurons (Fig. 5d) . In contrast, vGlut-Gal4 rescue of sss enhanced Shaker expression in the visual projection neurons (a-d) OK107-Gal4 was used to direct expression of GFP (a,c) or sss (b,d) and GFP or Shaker expression were examined, respectively. As Shaker was enriched in synapse-rich neuropil, GFP fused to synaptogamin (syt-GFP), which is targeted to the synapse, was used. GFP expression was seen in the mushroom bodies (a), but not in the group of visual projection neurons sending processes to the optic lobe (c). Transgenic expression of sss using OK107-Gal4 increased Shaker expression in the mushroom bodies (b), but not in the optic lobe (d).
(e-h) vGlut-Gal4 directed GFP expression in the visual projection neurons and the optic lobe (g), but not the mushroom bodies (e). Transgenic expression of sss using vGlut-Gal4 increased Shaker expression in the visual projection neurons and the optic lobe (h), but not in the mushroom bodies (f). Arrows point to the fiber bundles formed by the visual projection neurons. Maximal intensity projections of 7 1-µm sections from the anterior of the brain are shown for a,b,e and f, and a single 1-µm section from the posterior of the brain at the level of the protocerebral bridge is shown for c,d,g and h. Representative brains are shown, taken from two independent experiments (n = 5 or 6 for all genotypes). Scale bars represent 50 µm.
( Fig. 5h) but not in the mushroom bodies ( Fig. 5f) . Although it is possible that SSS exerts local non-cell-autonomous effects on Shaker levels, these data are consistent with a cell-autonomous role for SSS regulation of Shaker expression.
Rescue of SSS function at the neuromuscular junction
We next addressed whether SSS cell-autonomously regulates Shaker function in vivo by examining the synaptic signaling properties at the larval neuromuscular junction (NMJ), as a previous study of the hypomorphic sss qvr allele reported that functional properties at the NMJ are altered 32 . Pre-and postsynaptic phenotypes at the NMJ were assayed by measuring spontaneous miniature excitatory junctional potential (mEJP) frequency and the amplitude and kinetics of specific ionic currents, respectively. The mEJP frequency was significantly increased (P = 0.00009) in sss P1 mutant larvae compared with wild-type controls (Fig. 6a) .
A similar increase in the mEJP frequency was observed in Shaker Df mutant larvae (Fig. 6a) , indicating that disruption of either sss or Shaker leads to similar NMJ phenotypes. The increased mEJP frequency observed in sss P1 larvae was abolished by expression of SSS presynaptically using the pan-neuronal elav-Gal4 driver. In contrast, consistent with presynaptic release frequency reflecting glutamatergic motor neuron activity, expression of SSS in muscle with the 24B-Gal4 driver or in cholinergic neurons with the Cha-Gal4 driver failed to reduce the high mEJP frequency in sss P1 mutants (Fig. 6a) .
The magnitude and kinetics of the Shaker-dependent I A current in larval muscles was also altered in sss P1 mutants ( Fig. 6b-d) . The sss P1 mutation significantly delayed the time to peak (t peak ) of I A at 10 mV (P = 0.0003; Fig. 6b ) and also decreased the I A current magnitude at every voltage ≥−20 mV (Fig. 6c,d) . In contrast, the magnitude and kinetics of non-inactivating, Shaker-independent I K current were not altered in sss P1 mutants (Supplementary Fig. 7 ). The increase in t peak and the reduction in I A amplitude in sss P1 mutants were rescued by transgenic expression of SSS in muscle with 24B-Gal4 but not in neurons with elav-Gal4 (Fig. 6b,d) . It should be noted that only a partial rescue of I A amplitude was obtained with 24B-Gal4. Notably, a reduction in I A current was observed when SSS was overexpressed in muscles of wild-type animals using 24B-Gal4 (Supplementary Fig. 8 ), suggesting that the presence of excess SSS can impair Shaker function in muscle. Together, these electrophysiological results suggest that SSS regulates Shaker function in a cell-autonomous manner in both neurons and muscles.
SSS enhances Shaker channel function
We have shown that SSS is required for normal levels, localization and activity of Shaker in vivo. Bioinformatic prediction of SSS tertiary Figure 4 Altered Shaker expression and localization in sss mutants. (a-d) Shaker immunostaining of control iso31 (a,c) and sss ∆40 (b,d) wholemount adult brains. Maximal intensity projections from 1-µm sections from the entire brain are shown for a and b, whereas a single 1-µm section from the posterior aspect of the brain including the protocerebral bridge is shown for c and d. A 2× magnified inset is shown for d. (e-h) Shaker immunostaining in whole-mount adult thoracic ganglia of iso31 (e,g) and sss ∆40 (f,h). g and h are 2× magnified images from the boxed areas in e and f, respectively. α/α′ and γ indicate lobes of the mushroom bodies. cc, central connective; vpn, visual projection neurons. Representative images are shown from at least three independent experiments. n = 10 and n = 11 for iso31 and sss ∆40 brains, respectively, and n = 9 for iso31 and sss ∆40 thoracic ganglia. Scale bars represent 50 µm. Fig. 9 ) 12 . Furthermore, the sss gene contains two conserved intron breaks in the coding region shared by Ly-6/neurotoxin gene family members 34 (Supplementary Fig. 9 ).
The SSS protein also has other features of the Ly-6 domain, such as an N-terminal leucine/isoleucine and a C-terminal asparagine, as well as pairs of cysteine residues with characteristic spacing. Together, these observations suggest that SSS is a member of the Ly-6/neurotoxin superfamily. As many neurotoxins are known to act on ion channels, including Shaker-type K + channels 16, 35, 36 , the structural similarities between SSS and neurotoxins suggests that SSS might be an endogenous proto-toxin that binds to Shaker and regulates its activity.
To determine whether SSS affects Shaker channel activity, we coexpressed sss and Shaker heterologously and examined the effects on Shaker current amplitude and kinetics. We first recorded Shaker currents in human embryonic kidney (HEK-tsA) cells expressing wildtype Shaker in the presence or absence of sss (Fig. 7) . Coexpression with sss resulted in faster kinetics of Shaker current, significantly reducing t peak (P = 0.002; Fig. 7a,c) . A similar effect on the kinetics of Shaker current was observed with coexpression of SSS and wild-type Shaker channels in Xenopus oocytes (Fig. 7b,c) , whereas amplitude of Shaker current was largely unaffected ( Supplementary  Fig. 10) . Although the conditions used to coexpress Shaker and sss may not have been optimal to observe an effect on current amplitude, another potential explanation is that an additional component required for regulation of Shaker expression by SSS, which is present in Drosophila brain and muscle, is missing in oocytes. Taken together with the slower kinetics of I A current in sss P1 mutants (Fig. 6b,c) , these findings suggest that SSS enhances Shaker activity in vivo.
To assess whether SSS and Shaker can physically interact in a complex, we carried out co-immunoprecipitation experiments in Xenopus oocytes. When both sss and Shaker were expressed in oocytes, SSS was co-immunoprecipitated with Shaker ( Fig. 7d) . This interaction was specific, as SSS was not detected when immunoprecipitations were performed in the absence of Shaker. In summary, these data indicate that SSS can form a complex with and enhance the kinetic properties of Shaker. Cell-autonomous rescue of the sss phenotypes at the Drosophila larval NMJ. (a) mEJP frequencies for sss P1 and Shaker Df larvae were significantly increased relative to background controls. The UAS-sss transgene significantly decreased mEJP frequencies in the sss P1 mutant background only when combined with the elav-GAL4 driver. (b) The time-to-peak I A current (t peak ) was significantly greater in sss P1 than in background controls. The UAS-sss transgene significantly decreased I A t peak in the sss P1 mutant background only when paired with the 24B-Gal4 driver. (c) Representative traces of I A current illustrating the decrease in current magnitude and delayed time to peak in sss P1 mutant larvae. Dashed line is from wild type; solid line is from mutant muscle. a r t I C l e S
DISCUSSION
Our in vivo and in vitro results indicate that SSS is a regulator of Shaker expression, subcellular localization and activity, and is therefore an important modulator of nervous system function. Although SSS probably influences neuronal excitability at multiple anatomical loci, dissociation of the neural circuits responsible for sleep and ether-dependent leg-shaking suggests that the role of SSS in sleep regulation is distinct from its effect on motor control. Our data suggest that SSS acts on Shaker in a cell-autonomous manner and that expression of SSS in cholinergic neurons restores sleep in sss mutants, although unidentified noncholinergic neurons included in the Cha-Gal4 expression pattern may also be required. Because upregulation of Shaker by SSS in cholinergic neurons presumably decreases excitability and results in increased sleep, excitation of these cholinergic neurons is likely to promote wakefulness in Drosophila. Recent studies have demonstrated the involvement of monoaminergic signaling and GABA-responsive peptidergic cells in regulating wakefulness in Drosophila 21,23-25,30,37-39 . Thus, as in mammals 40 , sleep in Drosophila is controlled by arousal systems that include distinct populations of cholinergic, monoaminergic and peptidergic neurons. We found that SSS and Shaker were enriched in the same regions of the Drosophila brain and that SSS appeared to affect the subcellular distribution of Shaker. Thus, the distribution of Shaker channels in sss mutants shifted from an enrichment in processes to a predominance in cell bodies in brains and thoracic ganglia. In addition, loss of SSS or Shaker resulted in a reduction of the other protein, without a concomitant reduction in transcript, suggesting that these proteins stabilize each other in a complex. The reduction in Shaker protein in brains of sss mutants could be rescued by transgenic expression of SSS. However, we only observed partial rescue of muscle I A amplitude in sss mutants with overexpression of SSS in muscles. Consistent with this, we also found that overexpression of SSS in wild-type muscles reduced I A amplitude, suggesting that the presence of either too little or too much SSS can impair Shaker function, at least at the larval NMJ.
In addition to modulating the level of Shaker, SSS regulates the kinetics of Shaker-dependent potassium currents. The kinetics of Shaker-mediated I A potassium currents in muscle were selectively slower in sss mutants, a phenotype that could be rescued by targeted expression of sss in muscle. In transfected cells, coexpression of Shaker and SSS accelerated Shaker currents and resulted in detectable complex formation between the two proteins. Taken together, these data suggest that SSS directly interacts with Shaker to regulate its levels, localization and activity.
Properties of voltage-gated potassium channels, such as expression level, subcellular localization and gating characteristics, are influenced by a number of associated regulatory proteins, including Kvβ/Hyperkinetic, KCNEs, KChIPs and KChAP [41] [42] [43] . The in vivo relevance of these regulatory proteins is underscored by the finding that mutations in some of the genes encoding them are associated with human diseases, including Long QT syndromes 41, 43 . Unlike most other known regulators of voltage-gated potassium channels, which generally interact with cytoplasmic domains of channel proteins, SSS, as a GPI-anchored protein tethered to the plasma membrane, probably interacts with an extracellular domain of the Shaker channel. The predicted structure of SSS is also unlike those of other known endogenous regulators of voltage-gated potassium channels. Bioinformatic analysis predicts that SSS contains a compact disulfide-bonded betasheet structure (three-finger fold) found in the Ly-6/neurotoxin superfamily of proteins. This diverse family includes proteins involved in the modulation of receptor function and immune complex formation, as well as snake neurotoxins that bind the extracellular domains of various ion channels at the cell surface 12, 13, 15, 44 .
Unlike SSS, snake neurotoxins do not have GPI anchors. However, endoplasmic reticulum-targeted expression of soluble dendrotoxin, a specific blocker of Shaker-type potassium channels, results in increased surface expression of Kv1.1 (ref. 17 ), a mammalian ortholog of Shaker. This finding led to the proposal that an endogenous toxinlike protein tethers Shaker channels to the endoplasmic reticulum membrane and that dendrotoxin competes with this protein for binding to Shaker channels. SSS may be such an endogenous molecule regulating Shaker function and localization. However, rather than retaining Shaker in the endoplasmic reticulum, SSS appears to increase surface localization of the channel, either through promotion of Shaker trafficking to or retention at the cell surface.
Lynx1, another GPI-anchored neurotoxin/Ly-6 family member found in mammals, binds to and modulates the activity of a ligandgated ion channel (nicotinic acetylcholine receptor) 34, 45 . Thus, regulation of various ion channels by toxin-like GPI-anchored proteins may be an evolutionarily conserved mechanism, and SSS and Lynx-1 may be founding members of a family of cell-surface proto-toxins that modulate ion channel properties to control neuronal excitability and signaling. Although BLAST analysis with the primary sequence of SSS does not reveal an obvious mammalian ortholog 11 , there are a number of mammalian proteins with a Ly-6 domain and a GPI anchor, one of which may represent a functional homolog of SSS.
In summary, we found that SSS is a regulator of Shaker expression, localization and function in vivo. We propose that SSS acts as an endogenous proto-toxin that forms a complex with Shaker and promotes its stability and activity at the cell surface. As dysregulation of channel function causes a number of inherited human diseases, including migraine, epilepsy and cardiac arrhythmias 46, 47 , identification and characterization of additional toxin-like regulators of ion channels may prove to be a fruitful approach for discovering new treatment options for these diseases.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website. a r t I C l e S
ONLINE METHODS
Fly stocks and transgenic fly lines. All of the fly lines used in the behavioral experiments, including the Gal4 and UAS lines, were outcrossed at least five times into an isogenic white background (iso31) obtained from the Bloomington Stock Center. The Shaker Df line was obtained from D. Bushey and B. Ganetzky (University of Wisconsin) and the DAT fumin flies were obtained from K. Kume (Kumamoto University). eag sc29 (#1442), Cha-Gal4 (#6793), D42-Gal4 (#8816), OK107-Gal4 (#854), TH-Gal4 (#8848), repo-Gal4 (#7415), 24B-Gal4 (#1767) and elav-Gal4 (#458) were obtained from the Bloomington Stock Center. Sep54-Gal4 and Mai301-Gal4 were obtained from G. Korge (Freie University), and vGlut-Gal4 and dilp2-Gal4 were obtained from J. Simpson (Howard Hughes Medical Institute, Janelia Farm) and E. Rulifson (University of California, San Francisco), respectively. Other driver lines were obtained as previously described 19 . sss P1 and sss ∆40 were described previously 11 .
Transgenic fly lines carrying either the UAS-sss or sss-Gal4 construct were generated by standard techniques in the isogenic background iso31 (Rainbow Transgenics). For the UAS-sss construct, the entire coding region of sss was amplified by PCR using the following primers: 5′-GAA TTC ACC ATG TGG ACG CAG AGA AAT GCA GTT GG-3′ and 5′-GTC GAC GAG CCT AAC ACT TTC TAT CTG CTG AGC-3′. The PCR product was inserted into the EcoRI and XhoI restriction sites of pUAST, a P-element vector that contains the Gal4 binding sequence, UAS. The sss-Gal4 construct contained ~3.5 kb of the sss promoter, including the upstream intergenic region and the first and second introns of the sss gene. The following primers were used to amplify this region from wild-type genomic DNA: 5′-AAT CTA GAC TTG TAC TCT CAT GCG CTC-3′ and 5′-GCG GAT CCG CCT TGC CAC CCA CC-3′. The PCR product was inserted into the XbaI and BamHI restriction sites of the pPT-Gal transformation vector, upstream of the Gal4 coding sequence. Antibody generation. Because our previously described antibody raised against a peptide antigen poorly recognizes glycosylated SSS 11 and does not produce a SSS-specific signal in whole-mount brain samples, we raised a new antibody against glycosylated SSS. To produce soluble, glycosylated SSS protein, we inserted the coding region of sss lacking the C-terminal GPI-anchor signal into the pAcGP67A baculovirus transfer vector (BD BioSciences) via the following primers: 5′-TAC CCG GGG AAT GTC AAA CGC GAT CG-3′ and 5′-ATC TAG ACT ACT TGT CAT CGT CGT CCT TGT AGT CAT TGC ACA TAT CTT CCT CAC-3′. As the vector contains an N-terminal signal peptide, the native signal peptide was also removed from the sss coding region, and we added a C-terminal FLAG tag to facilitate purification. Expression and purification of soluble SSS protein was performed at the Protein Expression Facility of Wistar Institute. To ensure proper glycosylation, we expressed SSS protein in High-Five insect cells (Invitrogen). Soluble SSS protein, purified using an anti-FLAG M2 agarose bead column (Sigma), was used to generate a new polyclonal antibody, UPGP69, in a guinea pig (Cocalico Biologicals).
To generate an antibody to Shaker, we used a portion of the Shaker protein common to all isoforms fused to glutathione-S-transferase (GST). To generate this fusion construct, we amplified 215 amino acids by PCR using the following primers: 5′-AAG AAT TCA ATT TGC CCA AAT TGA GCA GTC AAG AC-3′ and 5′-AAT CTA GAG TCG ACA AGA TCT GTG ATG TCA GGC ACC TCG TCT TC-3′. The PCR product was subcloned into a modified pGEX vector (GE Lifesciences). GST-Shaker fusion protein was expressed in BL-21 cells (Novagen) and purified using glutathione sepharose beads (GE Life Sciences). After cleavage of GST using thrombin (GE Life Sciences), the Shaker antigen was used to generate a polyclonal antibody, UPR55, in a rat (Cocalico Biologicals).
western blot analysis and quantitative real-time PcR. Fly heads were homogenized and lysed in extraction buffer (20 mM HEPES, pH 7.5, 100 mM KCl, 20 mM β-glycerophosphate, 100 mM Na 3 VO 4 , 10 mM EDTA, 0.3% Triton X-100 (vol/vol), 1 mM DTT, and a cocktail of protease inhibitors) for 15 min at 4 °C. SDS sample buffer was added to head extracts and, after 5 min of boiling, extracts were loaded onto 4-12% NuPAGE gels (Invitrogen) for SDS-PAGE. Head extracts from seven females were loaded per lane. Antibodies to SSS (UPGP69), Shaker (UPR55) and Eag 48 were used at a 1:1,000 dilution and antibody to β-actin (Abcam) was used at 1:8,000. Extracts from Shaker Df flies were included in the diluted Shaker antibody solution to reduce nonspecific signal. Immunoreactive bands were visualized using enhanced chemiluminescence reagents (Pierce) and X-ray film. Films were scanned (Epson WorkForce 600) and imported into Photoshop 8.0 (Adobe) and the average intensity of each band was quantified using the histogram command. For background correction, the average intensity of the region immediately above or below the band of interest in the same lane was subtracted. To control for loading, we computed the ratio between the signal intensities of the band of interest and the actin band in the same lane. Quantitative real-time PCR was performed essentially as described 49 except that the following Shaker-specific primers were used: 5′-ATT ATC AGA GTG GTG GCC GAC T-3′ and 5′-CGT CTA AAG GGA CAT TGA CCG-3′. co-immunoprecipitation. cDNA encoding the ShakerD isoform in a modified pGEM9zf vector and cDNA encoding sss in a modified pBluescript vector were each linearized using NotI and used to generate cRNA with mMessage mMachine (Ambion). Xenopus laevis were handled according to protocols approved by the University of Pennsylvania Institutional Animal Care and Use Committee and anesthetized by immersion in 0.18% tricaine solution (wt/vol, Sigma). Oocytes were collected and dissociated in 25 mg ml −1 collagenase (Type I, Sigma) in 50% L-15 medium/50% 10 mM HEPES (pH 7.4) for 45 min at 21-23 °C. Oocytes were then washed with L-15/HEPES, incubated at 18 °C overnight and injected the following day with 1.4 ng of ShakerD cRNA and either 1.4 ng of sss cRNA or an equivalent concentration of transcription reaction mixture from which cDNA template was omitted. Following injection with cRNA, oocytes were maintained in L-15/HEPES at 18 °C until experiments were performed, 3-4 d later. We lysed 20 cells in extraction buffer (10 mM Tris, pH 7.4, 100 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.05% SDS (wt/vol) and complete protease inhibitors (Roche)). Precipitates were removed by microcentrifugation at 10,600 relative centrifugal force for 10 min at 4 C. We saved 5% of supernatants as a control for subsequent western blotting. The remaining supernatants were mixed with 1 µl of antibody to Shaker (UPR55) at 4 °C for 2 h. We used 30 µl of Dynal protein G-conjugated magnetic beads (Invitrogen) to precipitate Shaker-bound protein from solution overnight with shaking. Immunoprecipitates were washed six times with 1 ml of cold extraction buffer with the Triton X-100 concentration reduced to 0.5%. Western blotting was performed as described above.
Immunohistochemistry. Immunostaining of whole-mount brain samples was performed essentially as described 19 , except for the following modifications. For staining with antibody to Shaker, dissected brains were fixed in Bouin's fixative (Fisher) for 20 min at 4 °C. For staining with antibody to SSS, brains were fixed in 4% paraformaldehyde (wt/vol) in phosphate-buffered saline (1.86 mM NaH 2 PO 4 , 8.41 mM Na 2 HPO 4 and 175 mM NaCl) for 30 min at 21-23 °C. Antibodies to Shaker and SSS were used at 1:2,000 and 1:3,000 dilutions, respectively. Fluorescent secondary antibodies were used at 1:2,000 (Molecular Probes). To reduce nonspecific signal, we included extracts of Shaker Df or sss ∆40 mutant flies as additional blocking agents during incubation with antibodies to Shaker or SSS, respectively. Immunostained brain or thoracic ganglion samples for wildtype and mutant animals were processed at the same time and imaged with the same settings on a Leica TCS SP5 confocal microscope.
Behavioral assays. Flies were maintained on standard molasses-yeast-cornmeal food at 21-23 °C, and were entrained to a 12-h:12-h light:dark cycle for at least 2 d before being assayed for sleep. We monitored 3-7-d-old female flies using the Drosophila Activity Monitoring System (Trikinetics) at 25 °C and data were analyzed using MATLAB-based (MathWorks) custom software as described previously 11 . Sleep was identified as periods of inactivity lasting at least 5 min 2 . Ether-induced leg shaking was assayed as described previously 11 .
In vivo electrophysiology. Wandering third-instar larvae were immersed in a Ca 2+ -free saline (HL3.1) and dissected to access the neuromuscular junction, as described previously 50 . Recordings were collected from muscle 6 of hemisegments A3-A5 at 21-23 °C 50 by Sylgard-coated (Dow Corning) electrodes. The voltage-sensing and current-injection electrodes had initial resistances of 8-20 and 4-10 MΩ, respectively, when filled with a 2 M KCl solution with 10 mM EGTA (pH of 7.2 with KOH). The output of the amplifier (OC-725C, Warner) was low-pass filtered at 1 kHz (8-pole Bessel, model 902, Frequency Devices) and digitized using an AD/DA converter
